"There may be no population [of] patients whose health care and outcomes are more affected by racism than those with sickle cell disease," write Alexandra Power-Hayes and Patrick T. McGann in a paper for the New England Journal of Medicine.
Research on SCD has been chronically underfunded for decades, while similar diseases that affect primarily White Americans, such as cystic fibrosis, received as much as 10 times the funding.
[
add
]
[
|
|
...
]